Search…

Baili Tianheng: The II/III clinical trials of two combined medications from Iza-Bren have been approved.

01/04/2026

Bailey Tianheng Announcement: Recently received 2 official Drug Clinical Trial Approval Notices issued by the National Medical Products Administration. The company's independently developed innovative biopharmaceutical, iza-bren, has obtained approval for Phase II/III clinical trials of two combination therapies.

Latest

2 m ago

According to AI Express News, Dongwu Securities issued a research report on April 1, giving a "buy" rating to China Petroleum (601857.SH). The reasons for the rating mainly include: 1) the vigorous development of upstream oil and gas and new energy businesses; 2) impressive performance in the sales sector; 3) improvement in the transformation of the refining and chemical new materials business. (Daily Economic News)

2 m ago

The People's Bank of China, Ministry of Science and Technology, China Banking and Insurance Regulatory Commission, and China Securities Regulatory Commission jointly held a conference to exchange and promote the work of science and technology in finance.

2 m ago

Chilean Central Bank: Faced with uncertainty, the Monetary Policy Committee believes that maintaining interest rates unchanged at this meeting is "the most reasonable decision."

2 m ago

The Royal Bank of Canada has lowered Nike's target stock price from $78 to $70.

2 m ago

The People's Bank of China, the Ministry of Science and Technology, the China Banking and Insurance Regulatory Commission, and the China Securities Regulatory Commission jointly held a workshop to exchange ideas and promote progress in financial technology.

See all latest